Cargando…

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway

PURPOSE: In this study, we aimed to investigate the effect of follistatin (FST) on hepatic steatosis in NAFLD and the underlying mechanism, which has rarely been reported before. METHODS: Liver samples from NAFLD patients and normal liver samples (from liver donors) were collected to investigate hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Junlu, Cong, Li, Jia, Yingbin, He, Bai-Liang, Guo, Yifan, He, Jianzhong, Li, Decheng, Zou, Baojia, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621035/ https://www.ncbi.nlm.nih.gov/pubmed/36325432 http://dx.doi.org/10.2147/DMSO.S380053

Ejemplares similares

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling
por: Ma, Ning, et al.
Publicado: (2021)

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
por: Li, Liuran, et al.
Publicado: (2021)

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
por: Serrano-Maciá, Marina, et al.
Publicado: (2021)

Inactivating hepatic follistatin alleviates hyperglycemia
por: Tao, Rongya, et al.
Publicado: (2018)

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
por: Winbanks, Catherine E., et al.
Publicado: (2012)

HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway
por: Ding, Jiexia, et al.
Publicado: (2022)

Follistatin could promote the proliferation of duck primary myoblasts by activating PI3K/Akt/mTOR signalling
por: Li, Xinxin, et al.
Publicado: (2014)

Suppression of sirtuin 1 alleviates airway inflammation through mTOR-mediated autophagy
por: Wu, Yuanyuan, et al.
Publicado: (2020)

HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway
por: Chen, Jianxu, et al.
Publicado: (2019)

Pectic Bee Pollen Polysaccharide from Rosa rugosa Alleviates Diet-Induced Hepatic Steatosis and Insulin Resistance via Induction of AMPK/mTOR-Mediated Autophagy
por: Li, Xinzhi, et al.
Publicado: (2017)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
por: Lei, Sisi, et al.
Publicado: (2022)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Follistatin Alleviates Synovitis and Articular Cartilage Degeneration Induced by Carrageenan
por: Yamada, Jun, et al.
Publicado: (2014)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
por: Hu, Zhengyu, et al.
Publicado: (2022)

Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice
por: Wang, Wei, et al.
Publicado: (2020)

Moderate-intensity exercise alleviates pyroptosis by promoting autophagy in osteoarthritis via the P2X7/AMPK/mTOR axis
por: Li, Zihao, et al.
Publicado: (2021)

Electroacupuncture alleviates neuropathic pain caused by spared nerve injury by promoting AMPK/mTOR-mediated autophagy in dorsal root ganglion macrophage
por: Xu, Qian, et al.
Publicado: (2022)

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD
por: Miyata, Masaaki, et al.
Publicado: (2020)

MicroRNA-26a protects vascular smooth muscle cells against H(2)O(2)-induced injury through activation of the PTEN/AKT/mTOR pathway
por: Peng, Junlu, et al.
Publicado: (2018)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
por: Shih, Ping-Hsiao, et al.
Publicado: (2021)

Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
por: Duan, Jingya, et al.
Publicado: (2023)

The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2022)

COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR
por: Zhang, Chen-Yu, et al.
Publicado: (2022)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD
por: Wen, Ling, et al.
Publicado: (2022)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD
por: Ashworth, William B., et al.
Publicado: (2016)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
por: Wang, Haiying, et al.
Publicado: (2023)

RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway
por: Jiao, Yuheng, et al.
Publicado: (2022)

Correction: The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2023)

Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
por: Sztolsztener, Klaudia, et al.
Publicado: (2021)

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
por: He, Jichao, et al.
Publicado: (2019)

The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population
por: Yuan, Fan, et al.
Publicado: (2022)

miR-149 Alleviates Ox-LDL-Induced Endothelial Cell Injury by Promoting Autophagy through Akt/mTOR Pathway
por: Zhu, Zhongsheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vup7ngdmc851nrra059t4efs4n